Displaying 1..9 of 9 -
10
20
50
100
per page
Order by
number of views
addition date
New summary from Partneringdesk highlights trends in dealmaking from the top pharma and biotech companies
More
A dozen University of Western Ontario research projects, including ensuring innovative research on Metabolic Syndrome and personalized medicine, have received $19-million from the Ontario Research Fund.
More
Dr David Rees becomes Director of Medicinal Chemistry at Astex
More
Lawson Health Research Institute partners with MedManager to evaluate patient portals for cardiac rehabilitation, diabetes, and prostate cancer clinics
More
MARKETREADY(TM): a comprehensive, step-by-step process to help meet regulatory standards in pre-approval inspections.
More
SYN•X and Roche Diagnostics Cross-Licensing Agreement: An Important Step to Establish NT-proBNP as New Gold Standard for CHF Testing
More
Study helps doctors give better care to patients
More
SYN•X receives CE Mark allowing for sales of the Nexus Dx(tm) point-of-care cardiac product line in Europe
More
$6.5 million grant will aid the study cardiovascular bioengineering
More
Displaying 1..9 of 9 -
10
20
50
100
per page
Order by
number of views
addition date
Sep 2010 - 25 pages - $99
May 2011 - 396 pages - $2,265
Aug 2008 - 120 pages - $1,040
Apr 2011 - 250 pages - $2,695
Aug 2010 - 27 pages - $125
Dec 2010 - 18 pages - $125
Feb 2011 - 17 pages - $125
May 2011 - 20 pages - $125
Jul 2010 - 26 pages - $99